Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions

por Hummelink, Karlijn, Muller, Mirte, Linders, Theodora C., van der Noort, Vincent, Nederlof, Petra M., Baas, Paul, Burgers, Sjaak, Smit, Egbert F., Meijer, Gerrit A., van den Heuvel, Michel M., van den Broek, Daan, Monkhorst, Kim
Publicado 2019

Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II–IIIA NSCLC patients

por Vessies, Daan C. L., Schuurbiers, Milou M. F., van der Noort, Vincent, Schouten, Irene, Linders, Theodora C., Lanfermeijer, Mirthe, Ramkisoensing, Kalpana L., Hartemink, Koen J., Monkhorst, Kim, van den Heuvel, Michel M., van den Broek, Daan
Publicado 2022